Skip to main content

Table 1 Baseline characteristic

From: Frailty efficacy as a predictor of clinical and cognitive complications in patients undergoing coronary artery bypass grafting: a prospective cohort study

Characteristic

Overall,

N = 170†

Non-Frail,

N = 112†

Frail,

N = 58†

p-value*

Age

66.0 (62.0, 70.0)

66.0 (62.0, 70.0)

66.0 (62.0, 70.8)

0.938

Female

42 (24.7%)

21 (18.8%)

21 (36.2%)

0.012

Education

   

0.178

 Illiterate

40 (23.5%)

22 (19.6%)

18 (31.0%)

 

 Lower Diploma

74 (43.5%)

49 (43.8%)

25 (43.1%)

 

 Diploma & Upper

56 (32.9%)

41 (36.6%)

15 (25.9%)

 

BMI

26.06\(\pm\)3.25

26.05\(\pm\)3.30

26.09\(\pm\)3.19

0.671

EF

45.0 (40.0, 55.0)

50.0 (40.0, 55.0)

45.0 (40.0, 55.0)

0.259

CAG

   

> 0.999

 2VD

11 (6.5%)

7 (6.3%)

4 (6.9%)

 

 3VD

159 (93.5%)

105 (93.8%)

54 (93.1%)

 

Lab data

    

HB

13.34 (1.74)

13.60 (1.66)

12.83 (1.78)

0.004

CR

1.10 (0.90, 1.20)

1.10 (0.90, 1.20)

1.10 (0.90, 1.30)

0.487

FBS

100.5 (88.3, 136.8)

99.50 (87.0, 127.8)

104.5 (91.3, 146.0)

0.179

Blood glucose level

   

0.241

 Normoglycemic

121 (71.2%)

83 (74.1%)

38 (65.5%)

 

 Hyperglycemic

49 (28.8%)

29 (25.9%)

20 (34.5%)

 

TG

114.0 (92.0, 150.0)

110.5 (90.0, 140.8)

120.0 (94.3, 157.8)

0.359

CHOL

157.75\(\pm\)37.39

162.38\(\pm\)37.00

148.81\(\pm\)36.82

0.020

HDL

37.66\(\pm\)6.96

38.37\(\pm\)6.59

36.29\(\pm\)7.50

0.007

LDL

93.81\(\pm\)24.86

95.54\(\pm\)24.84

90.48\(\pm\)24.78

0.183

  1. BMI: Body Mass Index; EF: Ejection fraction; CAG: Coronary artery angiography; 2VD: two-vessel disease;
  2. 3VD: three-vessel disease; HB: Hemoglobin; CR: creatinine; FBS: Fasting blood sugar; TG: Triglycerides;
  3. CHOL: Cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein
  4. †n (%); Mean\(\pm\)SD; Median (IQR)
  5. *Pearson’s Chi-squared test; Wilcoxon rank sum test; independent t-test